Publications
150
Citations
4,139
Est. group size
—
Recurring co-author estimate
Active years
25
Publishing since 2002
Tamara S. Hannon conducts clinical research on diabetes, with a strong focus on children and adolescents. The work spans type 1 and type 2 diabetes, including clinical trials of medications (such as GLP-1 receptor agonists), studies of how the pancreas produces insulin, early detection through autoantibody screening, and childhood obesity prevention.
Publication activity rose to a peak around 2019-2020 and has slowed in recent years, averaging roughly 6-7 papers per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
Current awards run through May 2030 — about 4 years of funding on record from today. Awards are often renewed, so this is what is currently public, not a forecast.
Translation Core
6 earlier awards
- NIH DP3DK113183Apr 2017 – Mar 2022 · $1.9M awarded
Patient-Centered Decision Support to Improve Diabetes Management in Pre-Teens and Adolescents with Type 1 Diabetes
- NIH U01DK094438Sep 2011 – May 2020 · $594k awarded
Preservation of Beta Cell Function in Prediabetes Early Type 2 Diabetes
- NIH R01DK092717Jul 2012 – Mar 2016 · $403k awarded
Computer Automation for Diagnosis and Management of Childhood Type 2 Diabetes
- NIH R03HD057532Sep 2009 – Jul 2012 · $75k awarded
Impaired Sleep, Insulin Action, and Overweight in Youth
- NIH K23RR017250Sep 2002 – Aug 2007 · $121k awarded
Treatment of Crohn's Disease with Growth Hormone
- NIH M01RR000750Dec 2003 – Nov 2006 · $10k awarded
RX OF CROHN'S DISEASE W/GROWTH HORMONE RELEASING HORMONE VS PLACEBO
Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.
Typically publishes in teams of ~11 · 9% small-team papers (≤3 authors) · across 28 venues
- Predictors of Glycemic Worsening in the Next Year in Adults With Screen-Detected Type 2 Diabetes
Diabetes Obesity and Cardiometabolic CARE · 2026
- The Disposition Index in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes
2025
- Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet · 2025
- Trends of Diabetes in Youth (TrenDY) During COVID-19 Across the United States
The Journal of Clinical Endocrinology & Metabolism · 2025
- 1900-LB: Inpatient Education and Discharge Support in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
Diabetes · 2025
- GLP-1 Receptor Agonists and Acute Diabetes Complications in Adults with Type 1 Diabetes: A Target Trial Emulation
medRxiv · 2025
- The Disposition Index in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes
Diabetes · 2025
- The Disposition Index in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes
2025
- ISPAD Clinical Practice Consensus Guidelines 2024: Type 2 Diabetes in Children and Adolescents
Hormone Research in Paediatrics · 2024
- The Role of the Pediatrician in the Promotion of Healthy, Active Living
PEDIATRICS · 2024
- 1293-P: Real-World Status of Autoantibody Screening and Teplizumab Administration Readiness among Centers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
Diabetes · 2024
- Listening to the community: identifying obesity prevention strategies for rural preschool-aged children
UNC Libraries · 2024
- Obesity in Adolescents
New England Journal of Medicine · 2023
- Use of Genetically Modified Organism (GMO)-Containing Food Products in Children
PEDIATRICS · 2023
- Nonketotic hyperglycemic hemichorea‐hemiballismus in a pediatric patient: A case report
Clinical Case Reports · 2023
- Diabetes×28
- Diabetes Care×14
- PEDIATRICS×7
- The Journal of Clinical Endocrinology & Metabolism×4
- Author eBooks×4
- Robin Goland
Medicine · University of Michigan
- Manmohan K. Kamboj
Medicine · The Ohio State University
- Linda A. DiMeglio
Medicine · Indiana University
- William V. Tamborlane
Medicine · University of Michigan
- Inas H. Thomas
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Sep 1, 2026.
Claim or correct this profile